Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jaguar Health (JAGX) Revenue (2016 - 2025)

Jaguar Health (JAGX) has disclosed Revenue for 11 consecutive years, with $3.2 million as the latest value for Q4 2025.

  • Quarterly Revenue fell 7.81% to $3.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.5 million through Dec 2025, down 1.52% year-over-year, with the annual reading at $11.5 million for FY2025, 1.52% down from the prior year.
  • Revenue for Q4 2025 was $3.2 million at Jaguar Health, up from $3.1 million in the prior quarter.
  • The five-year high for Revenue was $11.6 million in Q4 2022, with the low at $20000.0 in Q1 2022.
  • Average Revenue over 5 years is $2.5 million, with a median of $2.5 million recorded in 2023.
  • Peak annual rise in Revenue hit 9535.0% in 2023, while the deepest fall reached 80.1% in 2023.
  • Over 5 years, Revenue stood at $2.1 million in 2021, then soared by 441.36% to $11.6 million in 2022, then plummeted by 80.1% to $2.3 million in 2023, then soared by 52.57% to $3.5 million in 2024, then dropped by 7.81% to $3.2 million in 2025.
  • According to Business Quant data, Revenue over the past three periods came in at $3.2 million, $3.1 million, and $3.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.